Sentences with phrase «in pharmaceutical litigation»

Pharmaceutical companies have teams of lawyers ready to defend them against any drug injury claim, so you will need a lawyer who has a track record of success in pharmaceutical litigation.

Contact An Attorney for You to be connected to a Yasmin Attorney Group that is experienced in pharmaceutical litigation.

Our firm is respected as a leader in products liability litigation and has a solid history of successfully representing plaintiffs in pharmaceutical litigation.

Not exact matches

Jazz said in a filing that it did so in response to the overall takeover environment for pharma companies and in light of a patent litigation settlement that allows Hikma Pharmaceuticals to sell a generic version of Xyrem with Jazz receiving royalty payments on those sales.

Leader in drug pricing litigation efforts against numerous pharmaceutical and medical device companies

Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing.

Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.

Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing.

The firms to have made it onto the Department of Health's civil litigation and arbitration in medicine and pharmaceuticals (CLAMP) panel are Peters & Peters, Capsticks, Hill Dickinson, Berwin Leighton Paisner (BLP) and Trowers & Hamlins.

After focusing on pharmaceutical patent and trade - mark litigation for most of her career, Paula now advises on IP strategy in the biotech sector.

In addition to representing pharmaceutical clients in Hatch - Waxman litigation, she has litigated patent matters involving medical devices, biotechnology, consumer products and electronics, computer networks, power and business methods, among other technologies and assetIn addition to representing pharmaceutical clients in Hatch - Waxman litigation, she has litigated patent matters involving medical devices, biotechnology, consumer products and electronics, computer networks, power and business methods, among other technologies and assetin Hatch - Waxman litigation, she has litigated patent matters involving medical devices, biotechnology, consumer products and electronics, computer networks, power and business methods, among other technologies and assets.

She also has experience counseling pharmaceutical companies in their patent, patent litigation and regulatory strategies internationally.

She has extensive experience trying large - scale patent litigation, nationally and internationally, relating to pharmaceutical patents and is currently lead trial counsel in several Hatch - Waxman cases.

John concentrates his practice on representing corporate clients in tort defense, products liability, mass torts, class actions, toxic torts, asbestos, litigation management, food liability, professional liability, pharmaceutical and medical device litigation, environmental litigation, intellectual property litigation, construction defect litigation, general liability, premises liability, and business and insurance disputes.

With deep experience in product liability matters and class action litigation, including catastrophic injury and wrongful death cases, as well as consumer fraud, he represents national and international companies, including manufacturers of motor vehicles, power tools, pharmaceuticals, clothing, glass products, outdoor power equipment, and industrial machinery.

We have the skills, experience and resources to handle complex litigation against the pharmaceutical companies, pharmacies, medical personnel and others who were involved in the process of overprescribing drugs to you or your loved one.

Ms. Werkema recently joined the firm's pharmaceutical litigation group, where she represents clients and their families adversely affected by Granuflo, a product used in dialysis that has caused countless deaths due to misleading and inadequate use instructions provided to health care professionals by its manufacturer.

V Andre Sherman is a trial lawyer specializing in the areas of product liability, pharmaceutical mass torts, consumer and employment class actions, and business litigation.

The report provides an interesting breakdown of which drug patents are the most challenged and which of the big pharmaceutical companies are involved in the most litigation.

She also represents pharmaceutical and medical device manufacturers in personal injury litigation.

Lorraine has provided consulting services on all phases of eDiscovery in litigation and investigations to public and private companies in various industries including energy and natural resources, financial services, telecommunications, healthcare, the pharmaceutical sector, and heavy manufacturing.

As an attorney with the New York litigation firm of Whitman Breed Abbott & Morgan (1990 - 2000), Mr. Scagnelli handled intellectual property counseling work and litigation for industrial clients, including Pharmaceutical Formulations, Inc. in Edison, New Jersey, then the second largest private label pharmaceutical company in the United States.

Mr. Buczko's practice focuses on patent litigation and he has represented clients in the biotechnology, pharmaceutical, chemical and electronics industries.

Andrew Kruppa chairs the Litigation Practice Group in Miami and focuses his practice on defending claims against manufacturers of pharmaceuticals and medical devices.

We offer full range of IP services for pharmaceutical clients, having multiple pharmaceutical lawyers on staff with years of experience in prosecution, opinion work, and litigation.

• improving the right of pharmaceutical companies to appeal a loss in certain specialized pharmaceutical patent litigation cases called «NOC proceedings.»

Represented multinational pharmaceutical company in product liability litigation in courts across the country and before the Judicial Panel on Multidistrict Llitigation in courts across the country and before the Judicial Panel on Multidistrict LitigationLitigation.

Fred Roth, an associate in Chicago, has experience working on litigation and regulatory compliance as it applies to medical devices and pharmaceuticals.

As one of the nation's leading lawyers in the emerging field of state unclaimed property laws, John devotes a substantial part of his practice to representing and advising a variety of manufacturers, retailers, distributors, financial institutions, pharmaceutical companies, telecommunications and transportation companies, utilities, service providers and other types of businesses on complex multi-state unclaimed property audits, litigation, voluntary disclosure agreements and transactional issues.

From aviation to food service and pharmaceuticals, Landherr has worked in a variety of industries throughout his career but he says there are certain aspects of the job — ensuring compliance, litigation management, contract review — that are the much same regardless of the industry.

We have defended hospitals, health systems and pharmaceutical and device manufacturers in government investigations and False Claims Act litigation.

Victory for pharmaceutical giants Pfizer in a product liability litigation about alleged cardiovascular injuries associated with testosterone replacement therapies

Following the U.S. Supreme Court's decision in Wyeth v. Levine that FDA approval does not preempt state tort liability for drug makers, state court decisions like this one will be an important battle ground in pharmaceutical companies» product liability litigation.

He also specialises in consultancy and assistance (participation to negotiations, drafting of contracts and litigation) to clients in the pharmaceutical field, in the High Tech field (equipment and software), in the automotive and in the aircraft fields.

Served on one of 5 designated trial teams for a Fortune 10 company in nationwide pharmaceutical litigation.

The attorneys at our firm have also represented clients in a variety of other class action cases, ranging from mass tort litigation, including asbestos claims, to pharmaceutical and medical devices.

Daniel Attaway represents pharmaceutical and biotech patent holders in Abbreviated New Drug Application («ANDA») and related patent litigation.

He was lead litigation and trial counsel for an international pharmaceutical company in its initial response to, investigation of, and litigation arising from an explosion that resulted in serious personal injuries and significant property damage.

She has extensive experience defending domestic and international medical device and pharmaceutical manufacturers in multi-plaintiff actions, as well as hospitals and physicians in medical malpractice actions in all stages of litigation, including trial.

In cases involving the Hatch - Waxman Act and issues involving the expiration of pharmaceutical patents and competition between branded drug companies and generic manufacturers, our antitrust litigation graphics can illuminate a complicated industry and a complex regulatory scheme as below:

Served as litigation counsel for major pharmaceutical company in test case of nationwide significance, involving allegations of Medicaid fraud.

Our product liability attorneys are actively involved in litigation involving the design and manufacturing of motor vehicles, airplanes, trains, glass bottles, tires, all terrain vehicles, motorcycles, pharmaceutical products, medical devices, machinery, construction equipment, boats, scuba diving equipment, farm equipment, electrical components, toys and various other consumer products.

John has previously represented the State of South Carolina Department of Health and Human Services and South Carolina Employee Insurance Program in lawsuits brought against a number of pharmaceutical companies in the Average Wholesale Price litigation.

Shrestha focuses his practice on all aspects of intellectual property law, including patent litigation, prosecution and opinion work in the chemical, pharmaceutical and electronic material arts.

Defense of leading U.S. pharmaceutical and biologic manufacturers in national and international product liability and commercial litigation involving prescription biologics, nonsteroidal pain medications, diet drugs, statins and other medications, including class actions, multi-district litigations, Congressional investigations, criminal proceedings, and shareholder derivative litigation

Serve as national counsel for a major pharmaceutical company in all aspects of its HRT litigation.

Dr. Nemirow specializes in intellectual property law with an emphasis on patent prosecution and litigation, particularly in the chemical, pharmaceutical, and biotech fields.

He practices commercial and intellectual property litigation in a variety of disciplines, including pharmaceutical patent litigation and Hatch - Waxman litigation.